FOSL2 participates in renal fibrosis via SGK1-mediated epithelial-mesenchymal transition of proximal tubular epithelial cells

Abstract Background Fos-related antigen 2 (FOSL2) plays a facilitative role in fibrotic disease; however, its role in renal fibrosis remains unclear. This study aimed to clarify the role and underlying mechanisms of FOSL2 in renal fibrosis. Methods Upregulated genes in unilateral ureteral obstruction (UUO)-injured kidneys were screened in Gene Expression Omnibus (GEO) databases, and overlapping genes were identified using Venn diagram software. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses were performed for these genes. The UUO-induced mouse model and transforming growth factor-β1 (TGF-β1)-induced cell model were used for the in vivo and in vitro studies. Results A total of 43 commonly upregulated genes were identified. GO and KEGG pathway analyses indicated that FOSL2 may be involved in fibrosis. Furthermore, FOSL2 was confirmed to be upregulated in UUO-injured kidneys and TGF-β1–induced cells. Knockdown of FOSL2 ameliorated interstitial fibrosis, extracellular matrix deposition, and epithelial-mesenchymal transition via the downregulation of fibronectin, α-smooth muscle actin (α-SMA), collagen type I (Col1a1 and Col1a2), and Col5a1 and upregulation of E-cadherin. Bioinformatics analysis revealed that serum/glucocorticoid regulated kinase 1 (SGK1) may be regulated by FOSL2 and involved in renal fibrosis. Further experiments confirmed that TGF-β1 enhanced SGK1 expression and transcription, which were reversed by FOSL2 silencing. Moreover, FOSL2 was bound to the SGK1 promoter, and SGK1 overexpression reversed the effects of FOSL2 silencing in TGF-β1–induced cells. Conclusion FOSL2 plays an essential role in promoting renal fibrosis in an SGK1-dependent manner, and targeting the FOSL2/SGK1 signaling axis may offer a potential strategy for the treatment of renal fibrosis.


INTRODUCTION
Chronic kidney disease (CKD) affects 10% of the population and has become a public health problem worldwide. [1]CKD not only contributes to the development of end-stage kidney disease (ESKD), but is also a risk factor for cardiovascular disease, which largely affects the health of patients. [2]enal fibrosis is a common outcome of various chronic renal diseases and is an irreversible injury characterized by excessive accumulation of collagen, fibronectin, and other extracellular matrix (ECM) components. [3]Epithelial-mesenchymal transition (EMT) in kidneys is a process by which renal tubular epithelial cells lose epithelial cell markers and transdifferentiate into a mesenchymal phenotype.It mainly contributes to organ scarring and plays an important role in the pathogenesis of renal fibrosis. [4]Renal fibrosis leads to renal parenchymal trauma and subsequent renal failure, which ultimately necessitates dialysis or kidney transplantation. [5]Thus, the prevention and inhibition of renal fibrosis are potentially effective approaches for preventing the progression of CKD.At present, effective therapeutic options to cure or reverse renal fibrosis are not available. [6]herefore, it is essential to explore the pathogenesis of renal fibrosis for its prevention and treatment.
The AP-1 transcription factor family consists of the FOS heterodimer and Jun homodimer and is involved in a variety of chronic diseases by regulating cellular processes. [7]10] A previous study reported that FOSL2 levels were elevated in skin biopsies from patients with systemic sclerosis. [11]tudies have shown that FOSL2, as a novel downstream mediator of transforming growth factor-β (TGF-β), is involved in the pathogenesis of systemic sclerosis and cardiac fibrosis and can promote collagen synthesis. [12,13]ew studies have suggested that FOSL2 plays a facilitative role during the progression of pulmonary fibrosis. [14]In addition, FOSL2 expression was significantly elevated in the renal tissues of a mouse unilateral ureteral obstruction (UUO) model of renal fibrosis. [15]However, whether FOSL2 regulates renal fibrosis has not yet been reported.
Serum/glucocorticoid regulated kinase 1 (SGK1) is a member of the AGC subfamily of protein kinases, which was first identified in rat mammary tumor cells. [16][19] Several studies have implicated a critical role of SGK1 in the pathophysiology of fibrosis. [20,21]In particular, SGK1 knockdown suppresses UUO-induced fibrosis by regulating the development of EMT, supporting the role of SGK1 in renal fibrosis progression. [20] the present study, we screened the significantly upregulated genes in UUO from the Gene Expression Omnibus (GEO) databases and obtained the commonly upregulated genes using Venn diagram software.Gene Ontology (GO) function and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis based on these upregulated genes indicated that FOSL2 might participate in the development of renal fibrosis.We further examined the functional role of FOSL2 in renal fibrosis in vivo and in vitro.We found that the expression levels of FOSL2 were elevated in the kidney tissues of UUO mice and TGF-β1-induced HK-2 cells.The kidneys of FOSL2-silenced mice showed a significant decrease in fibrotic lesions, collagen deposition, and EMT.Moreover, FOSL2 regulated SGK1 expression and bound to the SGK1 promoter.Therefore, the FOSL2/SGK1 profibrotic axis may be a promising biomarker and therapeutic target for renal fibrosis.

Animals and UUO model
Male C57BL/6 mice (20-25 g, 6-8 weeks) were kept under specific pathogen-free conditions.All procedures were approved by the Medical Ethics Committee of Shengjing Hospital of China Medical University (No. 2022PS602K) and conducted in accordance with the Guide for the Care and Use of Laboratory Animals.UUO operation was performed on mice as previously described. [22]Briefly, mice were anesthetized and a midline abdominal incision was made to expose the left ureter.The left ureter was ligated with 5-0 silk suture at two points and cut between the two ligations to obstruct completely.Mice in the sham group underwent the same operation without ligation.Six mice were sacrificed at 3, 7, and 14 days after the operation, and the left kidneys were collected for analysis.
T h e F O S L 2 s h R N A s e q u e n c e ( t a r g e t s i t e : 5'-GGACCUGCAGUGGAUGGUACA-3') was inserted into the pShuttle-CMV vector (Fenghuishengwu, Hunan, China; #BR009) at the BglII/SalI site and then packed into adenovirus.To knockdown FOSL2 in vivo, mice were infected with FOSL2-shRNA (shFOSL2) or NC-shRNA (shNC; empty vector) adenovirus (10 11 pfu) by tail vein injection once a week, and UUO was performed 2 days after the first injection.Mice were sacrificed at 14 days of UUO surgery and the left kidneys were collected for further detection.Mice were grouped as follows (six for each group): sham, UUO, UUO + shFOSL2, UUO + shNC.

Cell culture
The human proximal tubular epithelial cells (HK-2) were purchased from Procell Life Science and Technology Co., Ltd (Wuhan, China) (CL-0109).The cell line was validated by short tandem repeat profiling and tested for mycoplasma by polymerase chain reaction (PCR).HK-2 cells were cultured in Minimum Essential Medium (MEM; Solarbio, Beijing, China; #41500) supplemented with 10% fetal bovine serum (FBS; Procell, Wuhan, China; #164210) and placed in an incubator at 37℃ in the presence of 5% CO 2 .

Cell treatments
HK-2 cells were treated with 0, 10, 20, and 40 ng/mL TGF-β1 (Sino Biological, Beijing, China; #10804-HNAC) for 24 h to evaluate the induction of fibrosis by different concentrations of TGF-β1.For silencing FOSL2 and SGK1, the HK-2 cells were transfected with siRNA directed against FOSL2 and SGK1, respectively.To overexpress FOSL2 and SGK1, the HK-2 cells were transfected with FOSL2 or SGK1 overexpression vector.Lipofectamine 3000 transfection reagent (Invitrogen, Carlsbad, CA, USA; #L3000015) and plasmids were mixed and the cells were incubated for 24 h.After transfection, the HK-2 cells were seeded and maintained in complete medium overnight to confluency.Next, the cells were stimulated with 20 ng/mL TGF-β1 for 24 h.The cells were collected for analysis at the indicated times.

Bioinformatics analysis
Data related to UUO were obtained from GSE121190 and GSE97546 in GEO database (https://www.ncbi.nlm.nih.gov/).The GSE121190 database includes three pairs of fibroblast samples isolated from UUOinjured and uninjured mouse kidneys, respectively.The GSE97546 database contains two kidney samples from UUO-injured mice and three kidney samples from healthy mice.Significantly upregulated genes were identified by GEO2R program (https://www.ncbi.nlm.nih.gov/geo/geo2r/) according to the following standard: logFC > 2.5, P < 0.05.Venn analysis was performed with an online tool (https://www.omicstudio.cn/tool)to characterize overlapping upregulated genes between the two databases.For functional annotation of the overlapping genes, GO and KEGG pathway enrichment analysis were performed using the clusterProfiler package and visualized by R language.The GSE6379 database containing four FOSL2targeting siRNA and four control-siRNA samples was used to obtain FOSL2 downstream genes.To analyze genes significantly positively associated with FOSL2, the GSE6379 database was screened with the criteria of logFC > 1.5 and P < 0.05, and then GO and KEGG pathway analysis were performed.

RNA reverse transcription and quantitative realtime polymerase chain reaction
Total RNA was isolated from HK-2 cells or kidney tissues using TRIpure (BioTek Instruments, Winooski, VT, USA; #RP1001).The concentration of RNA samples was detected on a NANO 2000 UV spectrophotometer (ThermoFisher Scientific, Pittsburgh, PA, USA).The RNA samples were reverse transcribed into cDNA using BeyoRT II M-MLV Reverse Transcriptase (Beyotime Biotechnology, Shanghai, China; #D7160L).The cDNA templates were amplified with SYBR Green (Solarbio, Beijing, China; #SY1020) on an Exicycler 96 Real-Time PCR instrument (Bioneer Corporation, Daejeon, Korea).The expression of each target gene was normalized to endogenous glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and expressed as fold change compared to control.The primers used in this study are listed in Table 1.
For immunohistochemistry analysis, the 5-μm sections were subjected to antigen retrieval using a heat-based method and incubated with 3% H 2 O 2 (Sinopharm, Shanghai, China; #10011218) to eliminate endogenous peroxidase activity.
Images were visualized with an Olympus BX53 microscope and captured using DP73 system.

Luciferase reporter assay and transfection
The firefly luciferase reporter was constructed by a pGL3 vector inserted into the human SGK1 promoter regions (pGL3-SGK1).siFOSL2 or siNC was co-transfected into HK-2 cells with pGL3-SGK1 and the cells were incubated for 24 h according to the directions given in Lipofectamine 3000.The cells were then stimulated with TGF-β1 (20 ng/mL) for additional 24 h.Also, HK-2 cells were co-transfected with FOSL2 overexpression vector and pGL3-SGK1 containing four shortened SGK1 promoter fragments and cultured for 48 h.Firefly and Renilla luciferase activities were detected using the dualluciferase assay kit (KeyGEN BioTECH, Nanjing, China; #KGAF040).SGK1 transcriptional activity was expressed as the luminescence ratio of firefly to Renilla.

Statistical analysis
All values examined are expressed as the mean ± standard deviation for each group.GraphPad Prism7 software (GraphPad Software, San Diego, CA, USA) was used for the statistical analyses.One-way analysis of variance (ANOVA) was used for comparison of three or more groups.A P value of less than 0.05 was considered statistically significant.

Identification and functional annotation of the upregulated genes in a UUO-injured kidney
The databases (GSE121190 and GSE97546) were analyzed separately to identify genes that were upregulated in UUOinjured kidneys compared to those in normal kidneys.A total of 43 genes overlapped between the two datasets, as shown in the Venn diagram in Figure 1A.These overlapping upregulated genes were further analyzed using GO and KEGG pathway analyses.The upregulated genes were mostly enriched in collagen-containing ECM in the cellular component category (Figure 1B), ECM structural constituent in the molecular function category (Figure 1C), and ECM organization and collagen fibril organization in the biological process category (Figure 1D).KEGG pathway analysis revealed that the upregulated genes were significantly associated with ECM-receptor interaction, focal adhesion, the TGF-β signaling pathway, and the nuclear factor kappa B (NF-κB) signaling pathway (Figure 1E).The cnetplot of the GO and KEGG pathways showed significantly enriched upregulated genes in fibrosis-related functions and pathways (Figure 1F and 1G).

Expression of FOSL2 was upregulated in UUOinjured kidneys
Bioinformatics analysis suggested that FOSL2 might be involved in the process of renal fibrosis; therefore, we further validated this in a mouse UUO model (Figure 2A).As shown in Figure 2B, the protein expression of renal fibrosis-related markers (α-SMA, fibronectin, collagen type I) increased in the kidney tissues after UUO induction.
FOSL2 was expressed at low levels in the sham group, but was highly expressed in UUO-injured kidneys (Figure 2C).The upregulation of FOSL2 in the UUO model was confirmed by quantitative real-time polymerase chain reaction (qRT-PCR) and western blotting (Figure 2D).These findings indicate that FOSL2 was strongly expressed in the mouse UUO model of renal fibrosis.

Knockdown of FOSL2 improved UUO-induced renal fibrosis
To confirm the regulatory role of FOSL2 in kidney fibrosis, we knocked down FOSL2 by injecting a shFOSL2 adenovirus into UUO mice.The results of qRT-PCR and western blot analyses showed that the upregulation of FOSL2 in UUO mice was significantly reduced by the shFOSL2 adenovirus (Figure 3A).Renal tissue sections were subjected to H&E and Masson staining to examine renal histopathologic changes and the degree of fibrosis.As shown in Figure 3B-3D, tubular dilation, atrophy, and accumulation of collagen and fibrin in the tubulointerstitium were observed in UUO mice.Moreover, the tubulointerstitial fibrosis score was increased in the UUO group.However, kidney damage and fibrosis in UUO mice were mitigated after silencing FOSL2.The expression levels of α-SMA and fibronectin were increased, while that of E-cadherin was decreased in UUO mice (Figure 3E).The changes in these EMT-related proteins were further reversed by the downregulation of FOSL2.
Increased mRNA expression levels of collagen genes (Col1a1, Col1a2, and Col5a1) were also detected after UUO surgery (Figure 3F); however, these levels were decreased in FOSL2-silenced mice.These observations suggest that UUO-induced renal fibrosis was alleviated by FOSL2 knockdown.

Role of FOSL2 in TGF-β1-induced fibrotic transformation of HK-2 cells
TGF-β1 is a crucial profibrotic mediator of fibrotic diseases.HK-2 cells were incubated with TGF-β1 at different  concentrations for 24 h.The results showed that mRNA and protein expression levels of FOSL2 were upregulated in a time-dependent manner following TGF-β1 treatment (Figure 4A).Treatment with TGF-β1 also resulted in changes in fibrosis-associated gene expression (Figure 4B), manifested as upregulation of the expression levels of fibronectin, Col1a1, and Col1a2 and downregulation of the level of E-cadherin.Therefore, the stimulation of HK-2 cells with 20 ng/mL TGF-β1 for 24 h was considered as the optimal condition for the next study.HK-2 cells were then transfected with siFOSL2 and the interfering efficiency was measured at 24 h and 48 h.siFOSL2 treatment successfully reduced FOSL2 expression at both the mRNA and protein levels (Figure 4C).As shown in Figure 5A, TGF-β1-induced FOSL2 expression decreased after transfection with siFOSL2.High expression levels of fibronectin and collagen type I and low levels of E-cadherin were observed in TGF-β1-stimulated cells (Figure 5B), whereas the opposite result was observed in FOSL2silenced cells.In addition, immunofluorescence staining showed that treatment with TGF-β1 increased the level of fibronectin and decreased the level of E-cadherin, whereas these results were reversed by the silencing of FOSL2 (Figure 5C).These results demonstrated that FOSL2 was

Functional annotation of FOSL2 downstream genes
Functional annotation was performed on the FOSL2 downstream genes screened from the GSE6379 database.
In GO enrichment analysis (Figure 6A-6C), genes positively associated with FOSL2 were classified into the annotation terms of transcription regulator complex, G-protein α-subunit binding, protein serine/threonine phosphatase activity, and positive regulation of the canonical Wnt signaling pathway.KEGG pathway enrichment analysis (Figure 6D) showed that the FoxO, MAPK, PI3K-Akt, and NF-κB signaling pathways were remarkably related to these genes.The FOSL2 downstream genes enriched in the fibrosis-related categories of GO and KEGG pathways are shown in Figure 6E and 6F.

FOSL2 upregulated SGK1 expression by enhancing the activity of SGK1 transcription
Bioinformatics analyses and other studies have indicated that SGK1 is regulated by FOSL2 and is involved in the development of renal fibrosis. [20]To evaluate the crosstalk between FOSL2 and SGK1 in renal fibrosis, we initially examined the mRNA and protein expression levels of SGK1 in HK-2 cells with FOSL2 knockdown or overexpression.Our results showed that siFOSL2transfected cells had decreased levels of SGK1 (Figure 7A) and overexpression of FOSL2 enhanced SGK1 expression.The expression of SGK1 was upregulated in HK-2 cells after TGF-β1 treatment (Figure 7B), whereas FOSL2 silencing prevented this TGF-β1-induced effect.Based on these results, we hypothesized that FOSL2 positively regulated SGK1 expression in TGF-β1-induced cells.To confirm our hypothesis, we performed bioinformatics analysis and dual-luciferase experiments.Bioinformatics analysis showed that there were four potential FOSL2binding sites in the SGK1 promoter from -1737 bp to +21 bp (Figure 7C).The luciferase reporter assay showed that TGF-β1 treatment enhanced the luciferase activity of Fragment I (from -1737 bp to +21 bp), which was further attenuated by the silencing of FOSL2 (Figure 7D).This suggests that knockdown of FOSL2 can attenuate TGF-β1-induced activity of SGK1 transcription.After co-transfection with the FOSL2 overexpression vector, the reporter containing SGK1 promoter Fragment I (containing sites 1-4), Fragment II (containing sites 2-4), and Fragment III (containing sites 3-4) all showed high transcriptional activity (Figure 7E).When site 3 (from -1011 bp to -648 bp) was truncated, the fluorescence activity of Fragment IV (containing site 4) was greatly reduced and there was no significant change compared to that of the vector group, suggesting that site 3 was essential for FOSL2-mediated transcriptional activity of SGK1.These data demonstrated that FOSL2 regulated the expression and transcriptional activity of SGK1.

FOSL2 promoted TGF-β1-induced fibrotic transformation in HK-2 cells through SGK1
To further verify the function of SGK1 in TGF-β1-induced fibrotic transformation, HK-2 cells were treated with different concentrations of TGF-β1 for 24 h.Compared to the control group, the mRNA and protein expression levels of SGK1 were upregulated by TGF-β1 in a dose-dependent  manner (Figure 8A).SGK1 was silenced in HK-2 cells by siSGK1 transfection, and interference efficiency was detected at 24 and 48 h.As shown in Figure 8B, the mRNA and protein expression levels of SGK1 were significantly downregulated in the siSGK1 group.Further, TGF-β1enhanced SGK1 expression was eliminated by silencing SGK1 (Figure 8C).Meanwhile, upregulation of fibronectin and collagen type I and downregulation of E-cadherin were diminished in siSGK1-treated cells.The expression levels of fibronectin, collagen type I, and E-cadherin in FOSL2silenced cells were reversed by SGK1 overexpression (Figure 8D).The results for fibronectin and E-cadherin were further verified by immunofluorescence assay (Figure 8E).This evidence supports the SGK1-dependent profibrotic role of FOSL2 in TGF-β1-induced HK-2 cells.

DISCUSSION
The role of FOSL2 in renal fibrosis and its potential as a therapeutic target have not yet been investigated.Here, we identified 43 commonly upregulated genes in UUO-injured kidneys using the Venn diagram software in two GEO databases.GO and KEGG pathway enrichment analyses suggested that these genes may be associated with renal fibrosis.In vitro and in vivo results demonstrated that the expression of FOSL2 was dramatically upregulated in both UUO mice and TGF-β1-induced HK-2 cells.Knockdown of FOSL2 alleviated UUO-induced fibrosis by inhibiting collagen accumulation and EMT.Bioinformatics analysis and previous studies have demonstrated the critical role of SGK1 in renal fibrosis. [20]We identified SGK1 as an FOSL2 transcriptional target in HK-2 cells and uncovered the profibrogenic role of the FOSL2/SGK1 axis in vitro.Thus, the FOSL2/SGK1 axis may be a novel target for molecular-targeted therapies for renal fibrosis.
UUO is a classical animal model of renal fibrosis established by ligation of the ureter, which can be developed within a short time.TGF-β1 is the most important inducer of collagen synthesis and EMT and acts through the Smad signaling pathway. [24,25]TGF-β1 has been implicated in renal fibrosis due to its profibrotic properties and is commonly used to induce in vitro renal fibrosis models. [26,27]FOSL2, a protein of the Fos family, belongs to the AP1 transcription complex and may play a critical role in fibrotic diseases. [14]hus, we investigated the regulatory role of FOSL2 in renal fibrosis in UUO mice and in TGF-β1-treated HK-2 cells.
Previous studies have demonstrated an increase in FOSL2 expression during lung fibrosis and in systemic sclerosis models, [11,28] suggesting that upregulation of FOSL2 may be a common feature of many fibrotic disorders.Consistent with these findings, this study demonstrated that the expression of FOSL2 was upregulated in the UUO model of renal fibrosis and TGF-β1-treated HK-2 cells.Furthermore, knockdown of FOSL2 significantly decreased ECM deposition.
Fibrosis is a repair process triggered in response to injury, the dysregulation of which results in the pathological accumulation of ECM proteins, mainly collagen. [29]Collagen is synthesized by stromal cells and secreted into the ECM to provide structural support and act as cellular scaffolds. [30]ature collagen is crosslinked with lysine oxidases in the matrix, increasing its resistance to degradation and tensile strength. [31]Type I collagen is a crucial structural protein in the ECM and is considered a marker of fibrosis. [32]revious studies have reported that FOSL2 induces fibrosis by promoting collagen synthesis and ECM production. [13]n this study, Masson staining revealed the accumulation of collagen and fibrin in the tubulointerstitium of UUO mice.Knockdown of FOSL2 reduced collagen expression.Furthermore, UUO-induced downregulation of E-cadherin and upregulation of α-SMA were markedly mitigated by FOSL2 silencing, demonstrating the role of FOSL2 in promoting EMT.E-cadherin plays a key role in maintaining epithelial differentiation.Loss of E-cadherin causes tubular epithelial cells to lose polarity and acquire a mesenchymal phenotype when expressing α-SMA. [31]Yin et al. reported that FOSL2 promotes EMT, invasion, and migration, which are dependent on SNAI2 transcription. [33]Fibronectin is a dimeric glycoprotein that is responsible for structural support.It is involved in the regulation of adhesion, migration, and

Figure 1 :
Figure 1: Identification and functional annotation of upregulated genes in UUO.(A) Venn diagram showing 43 commonly upregulated genes in two datasets (green: GSE121190; blue: GSE97546).(B-D) The enrichment of overlapping upregulated genes in the GO terms of the CC (B), MF (C), and BP categories (D).(E) The enrichment of overlapping upregulated genes in the KEGG pathway.(F) The cnetplot of enriched GO clusters of upregulated genes.(G) The cnetplot of enriched KEGG pathways of upregulated genes.UUO: unilateral ureteral obstruction; GO: Gene Ontology; KEGG: Kyoto Encyclopedia of Genes and Genomes; CC: cellular component; MF: molecular function; BP: biological process.

Figure 4 :
Figure 4: FOSL2 expression is increased in TGF-β1-induced HK-2 cells.(A) qRT-PCR and western blotting analysis of FOSL2 in HK-2 cells treated with different concentrations of TGF-β1.(B) qRT-PCR analysis of mRNA expression levels of fibronectin, E-cadherin, Col1a1, and Col1a2.(C) The interfering efficiency of siFOSL2 was detected by qRT-PCR and western blotting analyses at 24 h and 48 h.The values are expressed as mean ± standard deviation.*P < 0.05 versus control group; **P < 0.01 versus control or siNC group.qRT-PCR: quantitative real-time polymerase chain reaction; TGF-β1: transforming growth factor-β1; FOSL2: fos-related antigen 2.

Figure 6 :
Figure 6: Functional annotation of FOSL2 downstream genes.(A-C) GO analysis of genes positively associated with FOSL2.(D) KEGG pathway analysis of genes positively associated with FOSL2.(E) The cnetplot of the GO enrichment analysis.(F) The cnetplot of the KEGG pathway enrichment analysis.CC: cellular component; MF: molecular function; BP: biological process; GO: Gene Ontology; KEGG: Kyoto Encyclopedia of Genes and Genomes.

Figure 7 :
Figure 7: FOSL2 upregulates SGK1 expression by enhancing the activity of SGK1 transcription.(A, B) The qRT-PCR and western blotting analysis of SGK1 in HK-2 cells after FOSL2 silencing or overexpression.(C) Schematic diagram of four potential FOSL2-binding sites and truncated fragments on the SGK1 promoter.(D) The regulation of FOSL2 on SGK1 transcription activity was evaluated by dual-luciferase assay.(E) A dual-luciferase assay was performed to detect the binding site of FOSL2 on SGK1 promoters.The values are expressed as mean ± standard deviation.**P < 0.01 versus siNC, vector, or control group; ## P < 0.01 versus TGF-β1 + siNC.qRT-PCR: quantitative real-time polymerase chain reaction; TGF-β1: transforming growth factor-β1; SGK1: serum/glucocorticoid regulated kinase 1; FOSL2: fos-related antigen 2.

Figure 8 :
Figure 8: FOSL2 promotes TGF-β1-induced fibrotic transformation in HK-2 cells through SGK1.(A) The mRNA and protein expression levels of SGK1 in the HK-2 cells treated with different concentrations of TGF-β1 were analyzed by qRT-PCR and western blotting analyses.(B) The interfering efficiency of siSGK1 was detected by qRT-PCR and western blotting analyses at 24 h and 48 h.(C) Western blotting analyses of the total protein expression levels of SGK1, fibronectin, collagen type I, and E-cadherin.(D) Western blotting analyses of the total protein expression levels of fibronectin, collagen type I, and E-cadherin.(E) Representative micrographs show fibronectin and E-cadherin expression in TGF-β1-treated HK-2 cells.Magnification: 400×.Scale bar: 50 µm.The values are expressed as mean ± standard deviation.**P < 0.01 versus control or siNC group.qRT-PCR: quantitative real-time polymerase chain reaction; TGF-β1: transforming growth factor-β1; SGK1: serum/glucocorticoid regulated kinase 1.

Figure 9 :
Figure 9: Diagram of the working model illustrating the mechanism of FOSL2 in renal fibrosis.FOSL2 was upregulated with the stimulation of UUO and TGF-β1 and facilitated SGK1 expression at the transcriptional level, leading to increased EMT and ECM deposition, which contributes to renal fibrosis.UUO: unilateral ureteral obstruction; TGF-β1: transforming growth factor-β1; EMT: epithelial-mesenchymal transition; ECM: extracellular matrix; SGK1: serum/glucocorticoid regulated kinase 1; α-SMA: α-smooth muscle actin.

Table 1 : Sequences of the primers used for RT-PCR
RT-PCR: reverse transcription-polymerase chain reaction